Search results
PROMOTED
Author(s):
Andrew Cook, Abdul Ihdayhid, Tomohiro Sakamoto ,et al
Start date:
Jan 21, 2026
Pacemaker implantation remains one of the most common complications after TAVI. In this webinar, chaired by Prof Rafal Dworakowski (Abbott APAC Medical Affairs Director, Singapore, SG) and Dr Simon Lam (Queen Mary Hospital, Hong Kong, HK), leading specialists will focus on the anatomy of the conduction system anatomy, highlight key pre-procedural planning considerations, and share proven…
View more
Author(s):
Mohamed Riad Abouzid
,
Ibrahim Kamel
,
Karim Ali
,
et al
Added:
1 week ago
OMI Confounded by LVH
Author(s):
Bayushi Eka Putra
,
Ignatius Yansen Ng
Added:
4 months ago
Case Report
Complete Revascularisation Following Acute MI
Author(s):
Ahmed Gonnah
,
Nadhrah Darke
,
Liam Mullen
,
et al
Added:
1 year ago
Review Article
Author(s):
Navin K Kapur
Added:
2 years ago
Author(s):
Navin K Kapur
Added:
1 week ago
ACC.26 – Dr Navin Kapur (Tufts Medicine, Boston, MA, US) joins us to discuss findings from the STEMI-Door To Unload (DTU) randomised clinical trial, examining whether primary left ventricular unloading with the Impella CP® device prior to reperfusion can reduce infarct size and heart failure-related outcomes in patients presenting with anterior ST-elevation myocardial infarction.This prospective,…
View more
Added:
2 weeks ago
Source:
Interventional Cardiology Review Journal
Long-term follow-up from the FAMOUS-NSTEMI trial suggests that a fractional flow reserve-guided strategy for managing patients with non-ST-segment elevation myocardial infarction (NSTEMI) does not reduce adverse cardiovascular outcomes compared to standard angiography-guided care.¹MethodologyFAMOUS-NSTEMI was a prospective, randomised, controlled trial that enrolled 350 patients with NSTEMI…
View more
Predilation in pPCI
Author(s):
Mahmoud Tantawy
,
Marwan Saad
,
Sherif Hussien
,
et al
Added:
11 months ago
Original Research
Added:
2 weeks ago
Source:
Cardiac Failure Review
The optimal timing for complete revascularisation in patients with ST-segment elevation myocardial infarction (STEMI) and multi-vessel disease who also present with heart failure is a key clinical question. A pre-specified subgroup analysis of the OPTION-STEMI trial suggests that a staged approach may be preferable to immediate complete revascularisation in this high-risk patient group…
View more
Author(s):
William O’Neill
Added:
2 years ago